CD274 and lung carcinoma: Despite the growing body of mechanistic evidence, the direct relationship between sex hormones and the PD-1/PD-L1 immune axis in lung cancer remains poorly understood, even though sex-based differences in immunotherapy outcomes have been consistently observed in clinical settings.